Abstract
Nanobiotechnology research has recently provided numerous basic and applied advances in the health sector. Nanocarriers have been developed for efficient drug delivery and diagnostic tools. Nanocarrier enables an effective, targeted biomolecular interaction in order to lower side effects caused during the treatment. Here, we review the problems associated with the conventional drug development and its delivery system. The efficacy of the treatment can be improved by the usage of efficient nanocarriers such as polymeric nanocarriers, superparamagnetic nanoparticles, quantum dot, dendrimers and lipid nanoparticles. We discuss the mechanisms of delivery. This review may aid in providing better solutions for unsolved problems that prevails with the day-to-day in silico, in vitro and in vivo drug delivery model development.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–183. https://doi.org/10.1016/j.addr.2010.10.008
Alivisatos AP (1996) Semiconductor clusters, nanocrystals, and quantum dots. Science 271:933–937. https://doi.org/10.1126/science.271.5251.933
Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–1822. https://doi.org/10.1126/science.1095833
AL-Sabagh AM, Maysour NE, El-Din MRN (2007) Investigate the demulsification efficiency of some novel demulsifiers in relation to their surface active properties. J Dispers Sci Technol 28:547–555. https://doi.org/10.1080/01932690701277237
Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H (2004) Skin penetration and distribution of polymeric nanoparticles. J Control Release 99:53–62. https://doi.org/10.1016/j.jconrel.2004.06.015
Arpicco S, Battaglia L, Brusa P, Cavalli R, Chirio D, Dosio F, Gallarate M, Milla P, Peira E, Rocco F, Sapino S, Stella B, Ugazio E, Ceruti M (2015) Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. J Drug Deliv Sci Technol 1:15. https://doi.org/10.1016/j.jddst.2015.09.004
Babincova M, Altanerova V, Altaner C, Cicmanex P, Babinec P (2004) In vivo heating of magnetic nanoparticles in an alternating magnetic field. Med Phys 31:2219–2221. https://doi.org/10.1118/1.1767101
Bajaj A, Rana S, Miranda OR, Yawe JC, Jerry DJ, Bunz UHF, Rotello VM (2010) Cell surface-based differentiation of cell types and cancer states using a gold nanoparticle-GFP based sensing array. Chem Sci 1:134–138. https://doi.org/10.1039/C0SC00165A
Balmert SC, Little SR (2012) Biomimetic delivery with micro- and nanoparticles. Adv Mater 24:3757–3778. https://doi.org/10.1002/adma.201200224
Bamrungsap S, Zhao Z, Chen T (2012) Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine 7:1253–1271. https://doi.org/10.2217/nnm.12.87
Barakat NS (2009) Magnetically modulated nanosystems: a unique drug-delivery platform. Nanomedicine 4:799–812. https://doi.org/10.2217/nnm.09.66
Bardal SK, Waechter JE, Martin DS (2011) Chapter 2-pharmacokinetics. Appl Pharmacol 17–34. https://www.elsevier.com/books/applied-pharmacology/9781437703108. Accessed 30 Aug 2018
Barenholz Y (2012) Doxil®—the first FDA-approved nano-drug: lessons learned. J Control Release 160:117–134. https://doi.org/10.1016/j.jconrel.2012.03.020
Barry SE (2008) Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperth 24:451–566. https://doi.org/10.1080/02656730802093679
Baskar G, George GB, Chamundeeswari M (2017a) Synthesis and characterization of asparaginase bound silver nanocomposite against ovarian cancer cell line A2780 and lung cancer cell line A549. J Inorg Organomet Polym Mater 27:87–94. https://doi.org/10.1007/s10904-016-0448-x
Baskar G, Lalitha K, Garrick BG, Chamundeeswari M (2017b) Conjugation, labeling and characterization of asparaginase bound silver nanoparticles for anticancer applications. Indian J Exp Biol 55:421–426. http://nopr.niscair.res.in/handle/123456789/42354. Accessed 30 Aug 2018
Baskar G, Garrick BG, Lalitha K, Chamundeeswari M (2018) Gold nanoparticle mediated delivery of fungal asparaginase against cancer cells. J Drug Deliv Sci Tec 44:498–504. https://doi.org/10.1016/j.jddst.2018.02.007
Basu S, Sandanaraj BS, Thayumanavan S (2004) Molecular recognition in dendrimers. In: Mark HF (ed) Encyclopedia of polymer science and technology, 4th edn. Wiley, New York, pp 385–424. https://doi.org/10.1002/0471440264
Berry CC (2009) Progress in functionalization of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 42:R198–R206. https://doi.org/10.1088/0022-3727/42/22/224003
Bhadra D, Bhadra S, Jain S, Jain N (2003) A PEGylated dendritic nanoparticulate carrier of florouracil. Int J Pharm 257:111–124. https://doi.org/10.1039/C39940000801:801
Bhatia S (2016) Chapter 2 nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. In: Natural polymer drug delivery systems. Springer, Switzerland, pp 33–93. https://www.springer.com/cda/content/document/cda_downloaddocument/9783319411286-c1. Accessed 30 Aug 2018
Bianco A (2004) Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin Drug Deliv 1:57–65. https://doi.org/10.1517/17425247.1.1.57
Bondi ML, Craparo EF, Giammona G (2007) Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies. Drug Dev 14:61–67. https://doi.org/10.1080/10717540600739914
Bradshaw DM, Arceci RJ (1998) Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol 16:3674–3690. https://doi.org/10.1200/JCO.1998.16.11.3674
Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP (1988) Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013–2016. https://doi.org/10.1126/science.281.5385.2013
Byrne JD, Betancourt T, Brannon-Peppas L (2008) Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615–1626. https://doi.org/10.1016/j.addr.2008.08.005
Cao YWC, Jin RC, Mirkin CA (2002) Nanoparticles with raman spectroscopic fingerprints for DNA and RNA detection. Science 297:1536–1540. https://doi.org/10.1126/science.297.5586.1536
Chamundeeswari M, Liji Sobhana SS, Jacob JP, Kumar M, PandimaDevi M, Sastry TP, Mandal AB (2010) Preparation, characterization and evaluation of a biopolymeric gold nanocomposite with antimicrobial activity. Biotechnol Appl Biochem 55:29–35. https://doi.org/10.1042/BA20090198
Chamundeeswari M, Sastry TP, Lakhsmi BS, Senthil V, Agostinelli E (2013) Iron nanoparticles from animal blood for cellular imaging and targeted delivery for cancer treatment. Biochim Biophys Acta 1830:3005–3010. https://doi.org/10.1016/j.bbagen.2012.12.031
Chang Y, Liu N, Chen L, Meng X, Liu Y, Li Y, Wang J (2012) Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. J Mater Chem 22:9594–9601. https://doi.org/10.1039/C2JM16792A
Chen J, Saeki F, Wiley BJ, Cang H, Cobb MJ, Li ZY (2005) Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett 5:473–477. https://doi.org/10.1021/nl047950t
Chou LY, Ming K, Chan WC (2011) Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev 40:233–245. https://doi.org/10.1039/c0cs00003e
Chowdary KPR, Rao YS (2004) Mucoadhesive microspheres for controlled drug release. Biol Pharm Bull 27:1717–1724
Chrastina A, Massey K, Schnitzer JE (2011) Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:421–437. https://doi.org/10.1002/wnan.143
Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 163:871–878. https://doi.org/10.1083/jcb.200304132
Danhier F, Feron O, Préat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–146. https://doi.org/10.1016/j.jconrel.2010.08.027
Das M, Datir SR, Singh RP, Jain S (2013) Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on florescent and radiolabeled, methotrexate-folic acid-multiwalled carbon nanotube conjugate. Mol Pharm 10:2543–2557. https://doi.org/10.1021/mp300701e
Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–782. https://doi.org/10.1038/nrd2614
de Groot FM, Albrecht C, Koekkoek R, Beusker PH, Scheeren HW (2003) Cascade-release dendrimers liberate all end groups upon a single triggering event in the dendritic core. Angew Chem Int Ed 42:4490–4494. https://doi.org/10.1002/anie.200351942
Derfus AM, Chen AA, Min DH, Ruoslahti E, Bhatia SN (2007) Targeted quantum dot conjugates for siRNA delivery. Bioconjugate Chem 18:1391–1396. https://doi.org/10.1021/bc060367e
Desai D, Zhang J, Sandholm J (2017) Lipid bilayer-gated mesoporous silica nanocarriers for tumor-targeted delivery of zoledronic acid in vivo. Mol Pharm 14:3218–3227. https://doi.org/10.1021/acs.molpharmaceut.7b00519
Deshpande PP, Biswas S, Torchilin VP (2013) Current trends in the use of liposomes for tumor targeting. Nanomedicine 8:1509–1528. https://doi.org/10.2217/nnm.13.118
El-Boubbou K, Zhu DC, Vasileiou C, Borhan B, Prosperi D, Li W, Huang X (2010) Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. J Am Chem Soc 132:4490–4499. https://doi.org/10.1021/ja100455c
Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–151. https://doi.org/10.1016/j.addr.2010.04.009
Freeman R, Liu X, Willner I (2011) Chemiluminescent and chemiluminescence resonance energy transfer (CRET) detection of DNA, metal ions, and aptamer-substrate complexes using hemin/G-quadruplexes and CdSe/ZnS quantum dots. J Am Chem Soc 133:11597–11604. https://doi.org/10.1021/ja202639m
Gan CW, Feng SS (2010) Transferrin-conjugated nanoparticles of Poly(lactide)-d-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier. Biomaterials 31:7748–7757. https://doi.org/10.1016/j.biomaterials.2010.06.053
Gao LY, Liu XY, Chen CJ, Wang JC, Feng Q, Yu MZ, Ma XF, Pie XW, Niu YJ, Qiu C, Pang WH, Zhang Q (2014) Core–shell type lipid-rPAA-Chol polymer hybrid nanoparticles for invivo siRNA delivery. Biomat 35:2066–2078. https://doi.org/10.1016/j.biomaterials.2013.11.046
Garcia MA (2011) Surface plasmons in metallic nanoparticles: fundamentals and applications. J Phys D Appl Phys 44:283001. https://doi.org/10.1088/0022-3727/45/38/389501
Geißler D, Charbonnie`re LJ, Ziessel RF, Butlin NG, Lohmannsroben HG, Hildebrandt N (2010) Quantum dot biosensors for ultrasensitive multiplexed diagnostics. Angew Chem Int Ed 49:1396–1401. https://doi.org/10.1002/anie.200906399
Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA (2009) Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 131:2072–2073. https://doi.org/10.1021/ja808719p
Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL (2007) Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 7:1929–1934. https://doi.org/10.1021/nl070610y
Gosk S, Moos T, Gottstein C, Bendas G (2008) VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochim Biophys Acta 1778:854–863. https://doi.org/10.1016/j.bbamem.2007.12.021
Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615–627. https://doi.org/10.1146/annurev.med.53.082901.103929
Grief AD, Richardson G (2005) Mathematical modelling of magnetically targeted drug delivery. J Magn Magn Mater 293:455–463. https://doi.org/10.1016/j.jmmm.2005.02.040
Haley B, Frenkel E (2008) Nanoparticles for drug delivery in cancer treatment. Urol Oncol Semin Orig Investig 26:57–64. https://doi.org/10.1016/j.urolonc.2007.03.015
Hallan SS, Kaur P, Kaur V, Mishra N, Vaidya B (2014) Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery. Artif Cells Nanomed Biotechnol 44:334–349. https://doi.org/10.3109/21691401.2014.951721
Han N, Zhao Q, Wan L (2015) Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. ACS Appl Mater Interfaces 7:3342–3351. https://doi.org/10.1021/am5082793
How CW, Rasedee A, Manickam S, Rosli R (2013) Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity. Colloids Surf B Biointerfaces 112:393–399. https://doi.org/10.1016/j.colsurfb.2013.08.009
Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006a) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128:2115–2120. https://doi.org/10.1021/ja057254a
Huang XY, Li L, Qian HF, Dong CQ, Ren JC (2006b) A resonance energy transfer between chemiluminescent donors and luminescent quantum-dots as acceptors (CRET). Angew Chem Int Ed 45:5140–5143. https://doi.org/10.1002/anie.200601196
Huang HC, Barua S, Sharma G, Dey SK, Rege K (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155:344–357. https://doi.org/10.1016/j.jconrel.2011.06.004
Iijima S (1991) Helical microtubules of graphitic carbon. Nature 354:56–58. https://doi.org/10.1038/354056a0
Imae T (2012) Physicochemical properties of dendrimers and dendrimer complexes. In: Cheng Y (ed) Dendrimer-based drug delivery systems. Wiley, Hoboken, pp 55–92. https://doi.org/10.1002/9781118275238.ch2
Jiang W, Kim BY, Rutka JT, Chan WC (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–150. https://doi.org/10.1038/nnano.2008.30
Jiang Y, Zhao H, Lin Y, Zhu N, Ma Y, Mao L (2010) Colorimetric assay for determination of lead (ii) based on its incorporation into gold nanoparticles during their synthesis. Angew Chem Int Ed Engl 49:4800–4804. https://doi.org/10.3390/s101211144
Kandekar SG, Río-Sancho S, Lapteva M, Kalia YN (2018) Selective delivery of adapalene to the human hair follicle under finite dose conditions using polymeric micelle nanocarriers. Nanoscale 10:1099–1110. https://doi.org/10.1039/C7NR07706H
Khoshnejad M, Parhiz H, Shuvaev VV, Dmochowski IJ, Muzykantov VR (2018) Ferritin-based drug delivery systems: hybrid nanocarriers for vascular immunotargeting. J Control Release 282:13–24. https://doi.org/10.1016/j.jconrel.2018.02.042
Kim DH, Kim KN, Kim KM, Lee YK (2008) Targeting to carcinoma cells with chitosan and starch coated magnetic nanoparticles for magnetic hyperthermia. J Biomed Mater Res 88:1–11. https://doi.org/10.1002/jbm.a.31775
Kim B, Han G, Toley BJ, Kim CK, Rotello VM, Forbes NS (2010) Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 5:465–472. https://doi.org/10.1038/nnano.2010.58
Kingsley JD, Dou H, Morehead J, Rabinow B, Gendelman HE, Destache CJ (2006) Nanotechnology: a focus on nanoparticles as a drug delivery system. J Neuroimmune Pharmacol 1:340–350. https://doi.org/10.1007/s11481-006-9032-4
Kommareddy S, Amiji M (2004) Chapter 10. Targeted drug delivery to tumor cells using colloidal carriers. In: Lu DR, Oie S (eds) Cellular drug delivery: principles and practice. Humana Press, Inc, Totowa, pp 181–215
Koo H, Huh MS, Sun IC, Yuk SH, Choi K, Kim K (2011) In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res 44:1018–1028. https://doi.org/10.1021/ar2000138
Kresge C, Leonowicz M, Roth W (2001) Dendrimers and dendrons. Concepts, syntheses, applications, vol 12. VCH, Weinheim, pp 7291–7309. https://doi.org/10.3390/molecules21040497
Kumari A, Singla R, Guliani A, Yadav SK (2014) Nanoencapsulation for drug delivery. EXCLI J 13:265–286
Lai PS, Lou PJ, Peng CL (2007) Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J Control Release 122:39–46. https://doi.org/10.1016/j.jconrel.2007.06.012
Lai Y, Chiang C, Kao T, Chen S (2018) Dual-drug nanomedicine with hydrophilic F127-modified magnetic nanocarriers assembled in amphiphilic gelatin for enhanced penetration and drug delivery in deep tumor tissue. Int J Nanomedicine 13:3011–3026. https://doi.org/10.2147/IJN.S161314
Lancet JE (2016) Final results of a phase III randomized trial of CPX-351 versus 7 + 3 in older patients with newly diagnosed high risk (secondary) AML. J Clin Oncol 34:7000. https://doi.org/10.1200/JCO.2016.34.15_suppl.7000
Lay CL, Liu HQ, Tan HR, Liu Y (2010) Delivery of paclitaxel by physically loading onto poly (ethylene glycol)(PEG)-graft carbon nanotubes for potent cancer therapeutics. Nanotechnology 21:065101–065111. https://doi.org/10.1088/0957-4484/21/6/065101
Lebold T, Jung C, Michaelis J, Brauchle C (2009) Nanostructured silica materials as drug-delivery systems for doxorubicin: single molecule and cellular studies. Nano Lett 9:2877–2883. https://doi.org/10.1021/nl9011112
Lee CC, Gillies ER, Fox ME (2006) A single dose of doxorubicin functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci 103:16649–16654. https://doi.org/10.1073/pnas.0607705103
Lee H, Fonge H, Hoang B, Reilly RM, Allen C (2010) The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharm 7:1195–1208. https://doi.org/10.1021/mp100038h
Levi-Polyachenko NH, Merkel EJ, Jones BT, Carroll DL, Stewart JH (2009) Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm 6:1092–1099. https://doi.org/10.1021/mp800250e
Li Y, Li N, Pan W, Yu Z, Yang L, Tang B (2017) Hollow mesoporous silica nanoparticles with tunable structures for controlled drug delivery. ACS Appl Mater Interfaces 9:2123–2129. https://doi.org/10.1021/acsami.6b13876
Linkous AG, Yazlovitskaya EM (2012) Novel therapeutic approaches for targeting tumor angiogenesis. Anticancer Res 32:1–12
Liu JM, Zhang DD, Fang GZ, Wang S (2018) Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery. Biomaterials 165:39–47. https://doi.org/10.1016/j.biomaterials.2018.02.042
Loo C, Lowery A, Halas NJ, West J, Drezek R (2005) Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 5:709–711. https://doi.org/10.1021/nl050127s
Lopez-Davila V, Loizidou M (2012) Organic nanocarriers for drug delivery. Curr Opin Pharmacol 12:414–419. https://doi.org/10.1016/j.coph.2012.02.011
Lu W, Huang Q, Geng KB, Wen XX, Zhou XX, Guzatov D (2010) Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials 31:2617–2626. https://doi.org/10.1016/j.biomaterials.2009.12.007
Lubbe AS, Bergmann C, Brock J, McClure DG (2000) Physiological aspects in magnetic drug targeting. J Magn Magn Mater 19:149–155. https://doi.org/10.1016/S0304-8853(98)00574-5
Ma P, Xiao H, Li C, Dai Y, Cheng Z, Hou Z, Lin J (2015) Inorganic nanocarriers for platinum drug delivery. Mater Today 18:554–564. https://doi.org/10.1016/j.mattod.2015.05.017
Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM (2011) A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine 6:2963–2979. https://doi.org/10.2147/IJN.S16923
Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592–599. https://doi.org/10.1016/j.tips.2009.08.004
Malik N, Evagorou EG, Duncan R (1999) Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10:767–776
Martinez-Carmona M, Colilla M, Vallet-Regi M (2015) Smart mesoporous nanomaterials for antitumor therapy. Nanomaterials 5:1906–1937. https://doi.org/10.3390/nano5041906
Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent. Cancer Res 46:6387–6392
Medintz IL, Farrell D, Susumu K, Trammell SA, Deschamps JR, Brunel FM (2009) Multiplex charge-transfer interactions between quantum dots and peptide-bridged ruthenium complexes. Anal Chem 81:4831–4839. https://doi.org/10.1021/ac900412j
Mi Y (2016) Enzyme-responsive multistage vector for drug delivery to tumor tissue. Pharmacol Res 113:92–99. https://doi.org/10.1016/j.phrs.2016.08.024
Mignani S, Tripathi RP, Chen L, Caminade A, Shi X, Majoral J (2018) New ways to treat tuberculosis using dendrimers as nanocarriers. Pharmaceutics 10:0105. https://doi.org/10.3390/pharmaceutics10030105
Mishra B, Patel BB, Tiwari S (2010) Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine 6:9–24. https://doi.org/10.1016/j.nano.2009.04.008
Mkerman MA, Chan WCW, Laakkonen P, Chatia SN, Ruoslahti E (2002) Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99:12617–12621. https://doi.org/10.1073/pnas.152463399
Moyano DF, Rotello VM (2011) Nano meets biology: structure and function at the nanoparticle interface. Langmuir 27:10376–10385. https://doi.org/10.1021/la2004535
Moyano DF, Rana S, Bunz UHF, Rotello VM (2011) Gold nanoparticle polymer/biopolymer complexes for protein sensing. Faraday Discuss 152:33–42. https://doi.org/10.1039/c1fd00024a
Muller RH (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 50:161–177
Muthukumar T, Chamundeeswari M, Prabhavathi S, Baskar G, Chandhuru J, Sastry TP (2014) Carbon nanoparticle from a natural source fabricated for folate receptor targeting, imaging and drug delivery application in A549 lung cancer cells. Eur J Pharm Biopharm 88:730–736. https://doi.org/10.1016/j.ejpb.2014.09.011
Mykhaylyk O, Antequera YS, Vlaskou D, Plank C (2007) Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 2:2391–2411. https://doi.org/10.1038/nprot.2007.352
Nacev A, Beni C, Bruno O, Shapiro B (2010) Magnetic nanoparticle transport within flowing blood and into surrounding tissue. Nanomedicine 5:1459–1466. https://doi.org/10.2217/nnm.10.104
Neri D, Bicknell R (2005) Tumour vascular targeting. Nat Rev Cancer 5:436–446. https://doi.org/10.1038/nrc1627
Ng CM, Loh HS, Muthoosamy K, Sridewi N, Manickam S (2016) Conjugation of insulin onto the sidewalls of single-walled carbon nanotubes through functionalization and diimide-activated amidation. Int J Nanomedicine 11:1607–1614. https://doi.org/10.2147/IJN.S98726
Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y (2006) Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice. J Control Release 114:343–347. https://doi.org/10.1186/1556-276X-7-565
Patil Y, Sadhukha T, Ma L, Panyam J (2009) Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. J Control Release 136:21–29. https://doi.org/10.1016/j.jconrel.2009.01.021
Patil H, Tiwari RV, Repka MA (2016) Recent advancements in mucoadhesive floating drug delivery systems: a mini-review. J Drug Deliv Sci Technol 31:65–71. https://doi.org/10.1016/j.jddst.2015.12.002
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760. https://doi.org/10.1038/nnano.2007.387
Pérez-Herrero E, Fernández-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79. https://doi.org/10.1016/j.ejpb.2015.03.018
Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:615–627. https://doi.org/10.1038/nrd2591
Pirollo KF, Chang EH (2008) Does a targeting ligand inflence nanoparticle tumor localization or uptake? Trends Biotechnol 26:552–558. https://doi.org/10.1016/j.tibtech.2008.06.007
Pirollo KF, Rait A, Zhou Q, Zhang X, Zhou J, Kim C, Benedict WF, Chang EH (2008) Tumor-targeting nanocomplex delivery of tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo. Clin Cancer Res 14:2190–2198. https://doi.org/10.1158/1078-0432.CCR-07-1951
Poon Z, Chang D, Zhao X, Hammond PT (2011) Layer-by-layer nanoparticles with a pH sheddable layer for in vivo targeting of tumor hypoxia. ACS Nano 5:4284–4292. https://doi.org/10.1021/nn200876f
Prabhu RH, Patravale VB, Joshi MD (2015) Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomed 10:1001–1018. https://doi.org/10.2147/IJN.S56932
Puri M, Barrow CJ, Verma ML (2013) Enzyme immobilization on nanomaterials for biofuel production. Trends Biotechnol 31:215–216. https://doi.org/10.1016/j.tibtech.2013.01.002
Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 26:83–90. https://doi.org/10.1038/nbt1377
Qian W, Sun D, Zhu R, Du X, Liu H, Wang S (2012) pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release. Int J Nanomed 7:5781–5792. https://doi.org/10.2147/IJN.S34773
Ramishetti S, Landesman-Milo D, Peer D (2016) Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles. J Drug Target 24:780–786. https://doi.org/10.3109/1061186X.2016.1172587
Riess G (2003) Micellization of block copolymers. Prog Polym Sci 28:1107–1170. https://doi.org/10.1016/S0079-6700(03)00015-7
Rosenblum D, Joshi N, Tao W, Karp JM, Peer D (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun 9:1410–1415. https://doi.org/10.1038/s41467-018-03705-y
Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson JE, Sahlgren C, Linden M (2010) Cancer-cell-specifi induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 6:1234–1241. https://doi.org/10.1002/smll.200902355
Ruoslahti E, Bhatia SN, Sailor MJ (2010) Targeting of drugs and nanoparticles to tumors. J Cell Biol 188:759–768. https://doi.org/10.1083/jcb.200910104
Saha K, Bajaj A, Duncan B, Rotello VM (2011) Beauty is skin deep: a surface monolayer perspective on nanoparticle interactions with cells and bio-macromolecules. Small 7:1903–1918. https://doi.org/10.1002/smll.201100478
Sala M, Diab R, Elaissari A, Fessi H (2018) Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm 535:1–17. https://doi.org/10.1016/j.ijpharm.2017.10.046
Santos HA, Bimbo LM, Peltonen L, Hirvonen J (2014) Inorganic nanoparticles in targeted drug delivery and imaging. In: Devarajan PV, Jain S (eds) Targeted drug delivery: concepts and design. Springer, Cham, pp 571–613. https://doi.org/10.1007/978-3-319-11355-5_18
Sega EI, Low PS (2008) Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev 27:655–664. https://doi.org/10.1007/s10555-008-9155-6
Semple SC (2010) Rational design of cationic lipids for siRNA delivery. Nat Biotech 28:172–176. https://doi.org/10.1038/nbt.1602
Shen Y, Zhang J, Hao W, Wang T, Liu J, Xie Y, Xu S, Liu H (2018) Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells. Int J Nanomed 13:537–553. https://doi.org/10.2147/IJN.S149942
Shi XY, Thomas TP, Myc LA, Kotlyar A, Baker JR (2007) Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys Chem Chem Phys 9:5712–5720. https://doi.org/10.1039/b709147h
Shi J, Kantoff PW, Wooster R, Farokhzad OC (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20–37. https://doi.org/10.1038/nrc.2016.108
Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–223. https://doi.org/10.1016/j.yexmp.2008.12.004
Stella B, Peira E, Dianzani C, Gallarate M, Battaglia L, Gigliotti CL, Boggio E, Dianzani U, Dosio F (2018) Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative. Nanomaterials 8:110–118. https://doi.org/10.3390/nano8020110
Stiriba SE, Frey H, Haag R (2002) Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. Angew Chem Int Ed 41:1329–1334
Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y (2014) Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed 53:12320–12364. https://doi.org/10.1002/anie.201403036
Tam YYC, Chen S, Cullis PR (2013) Advances in lipid nanoparticles for siRNA delivery. Pharmaceutics 5:498–507. https://doi.org/10.3390/pharmaceutics5030498
Tang QS, Zhang DS, Cong XM, Wan ML, Jin LQ (2008) Using thermal energy produced by irradiation of Mn–Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression. Biomaterials 29:2673–2679. https://doi.org/10.1016/j.biomaterials.2008.01.038
Tasciotti E (2008) Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nano 3:151–157. https://doi.org/10.1038/nnano.2008.34
Toma A, Otsuji E, Kuriu Y, Okamoto K, Ichikawa D, Hagiwara A (2005) A Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma. Br J Cancer 93:131–136. https://doi.org/10.1038/sj.bjc.6602668
Torchilin VP (2000) Drug targeting. Eur J Pharm Sci 11:S81–S91. https://doi.org/10.1016/S0928-0987(00)00166-4
Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–160. https://doi.org/10.1038/nrd1632
Torchilin VP (2010) Drug delivery (handbook of experimental pharmacology 197), vol 68. Springer, Berlin, pp 1521–1524. https://doi.org/10.1007/978-3-642-00477-3_2
Torchilin VP (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–135. https://doi.org/10.1016/j.addr.2010.03.011
Üner M, Yener G (2007) Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomed 2:289–300
van Landeghem FKH, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow R, Scholz R (2009) Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30:52–57. https://doi.org/10.1016/j.biomaterials.2008.09.044
Verma ML (2017) Nanobiotechnology advances in enzymatic biosensors for the agri-food industry. Environ Chem Lett 15:555–560. https://doi.org/10.1007/s10311-017-0640-4
Verma A, Stellacci F (2010) Effect of surface properties on nanoparticle–cell interactions. Small 6:12–21. https://doi.org/10.1002/smll.200901158
Verma ML, Barrow CJ, Kennedy JF, Puri M (2012) Immobilization of β-galactosidase from Kluyveromyces lactis on functionalized silicon dioxide nanoparticles: characterization and lactose hydrolysis. Int J Biol Macromol 50:432–437. https://doi.org/10.1016/j.ijbiomac.2011.12.029
Verma ML, Barrow CJ, Puri M (2013a) Nanobiotechnology as a novel paradigm for enzyme immobilization and stabilisation with potential applications in biofuel production. Appl Microbiol Biotechnol 97:23–39. https://doi.org/10.1007/s00253-012-4535-9
Verma ML, Chaudhary R, Tsuzuki T, Barrow CJ, Puri M (2013b) Immobilization of β-glucosidase on a magnetic nanoparticle improves thermostability: application in cellobiose hydrolysis. Bioresour Technol 135:2–6. https://doi.org/10.1016/j.biortech.2013.01.047
Verma ML, Naebe M, Barrow CJ, Puri M (2013c) Enzyme immobilisation on amino-functionalised multi-walled carbon nanotubes: structural and biocatalytic characterisation. PLoS ONE 8:e73642–e73642. https://doi.org/10.1371/journal.pone.0073642
Verma ML, Puri M, Barrow CJ (2016) Recent trends in nanomaterials immobilised enzymes for biofuel production. Crit Rev Biotechnol 36:108–119. https://doi.org/10.3109/07388551.2014.928811
von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ (2009) Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 69:3892–3900. https://doi.org/10.1158/0008-5472.CAN-08-4242
von Maltzahn G, Park JH, Lin KY, Singh N, Schwöppe C, Mesters R, Berdel WE, Ruoslahti E, Sailor MJ, Bhatia SN (2011) Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater 10:545–552. https://doi.org/10.1038/nmat3049
Wang Y, Xie X, Wang X, Ku G, Gill KL, O’Neal DP (2004) Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett 4:1689–1692. https://doi.org/10.1021/nl049126
Wang X, Wang Y, Chen ZG, Shin DM (2009) Advances of cancer therapy by nanotechnology. Cancer Res Treat 41:1–11. https://doi.org/10.4143/crt.2009.41.1.1
Wang Y, Brown P, Xia Y (2011a) Nanomedicine: swarming towards the target. Nat Mater 10:482–483. https://doi.org/10.1038/nmat3060
Wang Z, Tiruppathi C, Cho J, Minshall RD, Malik AB (2011b) Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life 63:659–667. https://doi.org/10.1002/iub.485
Wang AZ, Langer R, Farokhzad OC (2012) Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185–198. https://doi.org/10.1146/annurev-med-040210-162544
Wang Y, Zhao Q, Han N (2015) Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine 11:313–327. https://doi.org/10.1016/j.nano.2014.09.014
Wennerström H, Linman B (1979) Micelles. Physical chemistry of surfactant association. Phys Rep 52:1–86. https://doi.org/10.1016/0370-1573(79)90087-5
Yavuz MS, Cheng Y, Chen J, Cobley CM, Zhang Q, Rycenga M, Xie J, Kim C, Song KH, Schwartz AG, Wang LV, Xia Y (2009) Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 8:935–939. https://doi.org/10.1038/nmat2564
Yoo HS, Lee JE, Chung H, Kwon IC, Jeong SY (2005) Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. J Control Release 103:235–243. https://doi.org/10.1016/j.jconrel.2004.11.033
You CC, Miranda OR, Gider B, Ghosh PS, Kim IB, Erdogan B, Krovi SA, Bunz UH, Rotello VM (2007) Detection and identification of proteins using nanoparticle-fluorescent polymer ‘chemical nose’ sensors. Nat Nanotechnol 2:318–323. https://doi.org/10.1038/nnano.2007.99
Zhang J, Dubay MR, Houtman CJ, Severtson SJ (2009) Sulfonated amphiphilic block copolymers: syntheses, self-assembly in water, and applications as stabilizer in emulsion polymerization. Macromolecules 42:5080–5090. https://doi.org/10.1021/ma900795f
Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB (2013) Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5:205–218. https://doi.org/10.1002/wnan.1211
Zhao W, Karp JM (2009) Multifunctional nanoparticles as coupled contrast agents. Nat Mater 8:453–454. https://doi.org/10.1038/ncomms1042
Zhou Z (2009) Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery. Adv Funct Mater 19:3580–3589. https://doi.org/10.1002/adfm.200900825
Zhou J, Zhang X, Li M, Wu W, Sun X, Zhang L, Gong T (2013) Novel lipid hybrid albumin nanoparticle greatly lowered toxicity of pirarubicin. Mol Pharm 10:3832–3841. https://doi.org/10.1021/mp400303w
Zhu Y, Liao L (2015) Applications of nanoparticles for anticancer drug delivery: a review. J Nanosci Nanotechnol 15:4753–4773
Zhuo RX, Du B, Lu ZR (1999) In vitro release of 5-florouracil with cyclic core dendritic polymer. J Control Release 57:249–257. https://doi.org/10.1016/s0168-3659(98)00120-5
Acknowledgements
Authors would like to thank Director, Centre for Chemistry and Biotechnology, Deakin University Australia for providing research facility to carry out this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Chamundeeswari, M., Jeslin, J. & Verma, M.L. Nanocarriers for drug delivery applications. Environ Chem Lett 17, 849–865 (2019). https://doi.org/10.1007/s10311-018-00841-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10311-018-00841-1